CD274 and non-small cell lung carcinoma: In Table 4, we present PD1/PDL1 monoclonals in previously treated NSCLC as an example to illustrate how scan frequency might be adjusted with 2‐phase decay, as the proportion of the remaining population coming from the rapidly progressing group decreases.